Fatty acid modified forms of glucocorticoids
US7390796B2 · kind B2 · utility
0Cited by
12References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 14, 2006 |
| Grant date | Jun 24, 2008 |
| Priority date | — |
| Expiry date | Nov 14, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J71/0031
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds are disclosed of the formulain which R3 is C8 to C24 hydrocarbon or the residue of misoprostol. The compounds are useful for treating rhinitis and asthma, particularly by inhalation, and for treating inflammation, particularly by local or topical administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.